The Food and Drug Administration has issued an urgent nationwide recall for a popular energy supplement after laboratory analysis uncovered the presence of an undeclared prescription-strength erectile dysfunction medication within the product.
Serious Health Concerns Prompt Immediate Action
Akkarco LLC, the manufacturer, has voluntarily recalled its Ashfiat Alharamain Energy Support dietary supplement following tests that confirmed it contains tadalafil. This active pharmaceutical ingredient is commonly found in prescription medications used to treat erectile dysfunction and is strictly prohibited from inclusion in over-the-counter dietary supplements.
Undisclosed Ingredient Poses Significant Dangers
Health officials have emphasised that tadalafil, classified as a phosphodiesterase-5 inhibitor, was not declared anywhere on the product's labelling. This omission creates potentially dangerous situations for consumers who might unknowingly ingest the substance.
The FDA's recall notice highlights multiple serious health risks associated with unintended tadalafil consumption, particularly for vulnerable individuals. These risks include:
- Cardiovascular complications and irregular heart rhythms
- Dangerous fluctuations in blood pressure
- Severe dizziness and disorientation
- Persistent headaches and migraines
These adverse effects are especially concerning for people with pre-existing medical conditions or those taking other prescription medications that might interact negatively with tadalafil.
Product Details and Distribution Channels
The affected supplement is packaged in distinctive glass bottles featuring orange labelling. The specific batch involved carries the identification number ENCOT24 and has an expiration date of October 2028.
This product achieved nationwide distribution through major online retail platforms, with Amazon confirmed as one of the primary sales channels. The widespread availability through digital marketplaces has prompted health authorities to issue broad consumer warnings.
Official Recommendations for Consumers
Regulatory bodies and health experts have issued clear guidance for anyone who may have purchased this supplement:
- Immediately discontinue use of the Ashfiat Alharamain Energy Support product
- Carefully check any remaining supplements for batch number ENCOT24
- Consult with a healthcare professional if any adverse symptoms have been experienced
- Report any side effects to the appropriate health authorities
This incident represents another significant case in the ongoing regulatory challenges surrounding dietary supplement safety and accurate ingredient disclosure. The discovery of prescription medications in products marketed as natural supplements continues to raise serious questions about manufacturing standards and consumer protection measures within the industry.
